Skip to main content
Back to BlackRock

BlackRock's Pharmaceutical Portfolio

Browse 7 Pharmaceutical companies funded by BlackRock. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
7
Total Funding in Pharmaceutical
$814.3M

Pharmaceutical Portfolio Companies (7)

Export
BiopharmaBiotechnologyHealth DiagnosticsPharmaceuticalTherapeutics

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Westlake Village, United States
February 2024
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

San Diego, United States
February 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

Oxford, United Kingdom
December 2023
$2.3M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Waltham, United States
December 2024
$30.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Burlingame, United States
January 2026
$201.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Somerville, United States
October 2022
$121.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

Shanghai, China
October 2020
$310.0M
Series A

Founder Contacts

30,000+ verified contacts

Explore BlackRock's Full Portfolio

View all companies funded by BlackRock across every industry and funding stage.

View Full BlackRock Portfolio